论文部分内容阅读
2005年,上海市政府已把进一步推进实施“三医联动”改革列为今年重点工作之一,在医药产业中,出口退税下降;原材料、辅料、包材、燃料进一步提价;随着国家医保体系的健全,企业承担的费用进一步增加;在医药市场上,在全国医药企业的GNP改造和认证工作基本完成后,各制药企业都不约而同地把目光集中在增加品种和拓展市场上;第二轮的大输液与针剂的GMP认证又将展开,它对于企业在“软件”上有更高的要求,此外,所有的制药企业还面临一个如何提高设备利用率,降低动作成本的问题。面对种种困难,205年1-2月,上海制药工业还是取得了十分可喜的成绩。
In 2005, the Shanghai municipal government has listed as one of its key tasks this year the reform of “three medical linkage” to further promote the implementation of the reform. In the pharmaceutical industry, export tax rebates have dropped; raw materials, auxiliary materials, packaging materials and fuels have further increased their prices; In the pharmaceutical market, after the completion of the GNP reform and certification of pharmaceutical enterprises in the country, the pharmaceutical companies are invariably focusing on increasing variety and expanding the market. In addition, all pharmaceutical companies also face a problem of how to improve equipment utilization and reduce operating costs . Faced with various difficulties, from January to February in 205, the pharmaceutical industry in Shanghai still achieved very gratifying results.